Can bleeding in trabeculectomy be decreased? Effectiveness of brimonidine pre-treatment

Purpose To evaluate the efficacy of preoperative topical brimonidine use to maintain visibility during trabeculectomy and control intraoperative bleeding and postoperative subconjunctival hemorrhage. Methods The first group comprised 35 eyes of 34 patients administered brimonidine tartrate 0.15% (Brimogut, Bilim Ilac, Turkey) eye drops 6 and 3 min before surgery, and 33 eyes of 31 patients who received no medication for vasoconstriction formed the second group. Preoperative and postoperative photographs and operation video images were taken and vision analysis software used. Black-and-white images were obtained to identify the blood vessel and surface hemorrhage areas. The surface area of the hemorrhage was calculated by counting the black pixels with Image J software. Results There was no significant difference between two groups in terms of baseline (preoperative) eye redness (p > 0.05). In the first group, the eye redness values were 344.7 +/- 19.5 pixels preoperatively and 244.1 +/- 23.3 pixels at the beginning of the surgery, respectively (p < 0.001). However, no significant change was observed in the second group in eye redness (348.2 +/- 17.5 pixels preoperatively and 360.7 +/- 26.8 pixels at the beginning of the surgery, p > 0.05). Cautery was used for an average of 11.91 +/- 1.96 s in the first group and 25.57 +/- 4.66 s in the second to control intraoperative bleeding (P < 0.001). Conclusion Preoperative topical brimonidine use in trabeculectomy surgery significantly decreased intraoperative bleeding and postoperative subconjunctival hemorrhage and facilitated bleeding control.

Automated summary

The study demonstrates that the preoperative use of topical brimonidine can significantly reduce intraoperative bleeding and postoperative subconjunctival hemorrhage during trabeculectomy, making bleeding control easier.